MedPath

Effects of brewed tea of poulk in rheumatoid arthritis

Not Applicable
Conditions
Rheumatoid Arthritis.
Rheumatoid arthritis, unspecified
Registration Number
IRCT2015032011335N5
Lead Sponsor
Connective Tissue Diseases Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

Subjects diagnosed with rheumatoid arthritis based on American College of Rheumatology and European League Against Rheumatism (ACR-EULAR) 2010 criteria for RA; Desire to attend in the study and signing the informed consent form; Desire to fill in the questionnaires and participate in sampling; Age range of 30 to 65 years; Being diagnosed with active rheumatoid arthritis (disease activity score-28 more than 3.2); Not receiving antioxidant or anti-inflammatory supplements since one month prior to the study
Exclusion criteria: Pregnancy; Lactation; Presence or history of other kinds of diseases and cancers; Other acute or chronic inflammatory diseases (such as colitis, psoriasis); AIDS; Sepsis; Type 2 diabetes mellitus; Thyroid disorders; Having side effects with poulk consumption besides drug side effects; Severe obesity (body mass index more than 40); Taking antioxidant supplements during the study; Smoking or being a passive smoker; Changing diet, physical activity and lifestyle during the study period; Unwillingness to continue the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Outcomes (disease activity score in 28 joints). Timepoint: Before and after the 8-week intervention. Method of measurement: Using validated questionnaire.;Serum levels of inflammatory factors (intelukin-1, tumor necrosis factor-alpha, high sensitive-c reactive protein). Timepoint: Before and after the 8-week intervention. Method of measurement: Using commercially available kits and ELISA method.;Serum levels of matrix metalloproteinases: matrix metalloproteinase-1 and matrix metalloproteinase-3. Timepoint: Before and after the 8-week intervention. Method of measurement: Using commercially available kits and ELISA method.
Secondary Outcome Measures
NameTimeMethod
Dietary intake of energy and nutrients. Timepoint: Before and after the 8-week intervention. Method of measurement: Using 3-day dietary record.;Anthropometric parameters (height, weight, body mass index, waist and hip circumferences). Timepoint: Before and after the 8-week intervention. Method of measurement: Body weight is measured using a calibrated scale (Seca, Germany) to the nearest 0.5 kilogram. Standing height without shoes and circumferences of waist and hip are measured using a non-stretchable tape (Seca) to the nearest 0.5 centimeters. Body mass index is calculated through dividing weight (kilogram) by the height squared (meters).
© Copyright 2025. All Rights Reserved by MedPath